| 產品詳情 |
| Edit |   |
|---|
| Product Name | BX 471 |
|---|
| Description | Potent, selective non-peptide CCR1 antagonist (Ki = 1 nM for human CCR1). Exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. Inhibits MIP-α/CCL3-induced intracellular Ca2+ mobilization. Orally active; effectively reduces disease severity in a rat model of multiple sclerosis. Decreases renal fibrosis in a mouse model of obstructive nephropathy. Purity 98%. MW (observed): 434.89 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (2R)-1-[[2-[(Aminocarbonyl)amino]-4-chlorophenoxy]acetyl]-4-[(4-fluorophenyl)methyl]-2-methylpiperazine |
|---|
| Gene, Accession, CAS # | CAS: 217645-70-0 |
|---|
| Catalog # | 3496/10 |
|---|
| Price | |
|---|
| Order / More Info | BX 471 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|